Xin Lü
Impact in
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism
- Oncology top 1%
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Bone health and treatments
Papers in
- Epidemiology 52
- Inflammatory Myopathies and Dermatomyositis 41
-
- Epigenetics and DNA Methylation 7
- Co-authors
- Yibin Kang (18 shared papers)Peter Cram (8 shared papers)Yue Li (2 shared papers)Stephen L. Kates (1 shared paper)Jasvinder A. Singh (1 shared paper)Brian R. Wolf (1 shared paper)Qinglin Peng (35 shared papers)Guochun Wang (35 shared papers)
- Journals
- Cancer Research (9 papers)Clinical Rheumatology (5 papers)Scientific Reports (5 papers)Clinical and Experimental Rheumatology (4 papers)Cancers (4 papers)
- Partner nations
- ChinaUnited StatesPuerto Rico
In The Last Decade
Xin Lü
178 papers receiving 7.2k citations
Xin Lü's Hit Papers
Peers
Comparison fields: 5 of 158
- Cancer Research 1.2k
- Oncology 2.0k
- Immunology 1.3k
- Rheumatology 449
- Molecular Biology 2.1k
Countries citing papers authored by Xin Lü
This map shows the geographic impact of Xin Lü's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xin Lü with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xin Lü more than expected).
Fields of papers citing papers by Xin Lü
This network shows the impact of papers produced by Xin Lü. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xin Lü. The network helps show where Xin Lü may publish in the future.
Co-authors
The 25 scholars most cited alongside Xin Lü, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 192 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Total Knee Arthroplasty Volume, Utilization, and Outcomes Among Medicare Beneficiaries, 1991-2010 Hit paper breakdown → | 2012 | 754 |
| 2 | Hypoxia and Hypoxia-Inducible Factors: Master Regulators of Metastasis Hit paper breakdown → | 2010 | 560 |
| 3 | VCAM-1 Promotes Osteolytic Expansion of Indolent Bone Micrometastasis of Breast Cancer by Engaging α4β1-Positive Osteoclast Progenitors Hit paper breakdown → | 2011 | 403 |
| 4 | Effective combinatorial immunotherapy for castration-resistant prostate cancer Hit paper breakdown → | 2017 | 402 |
| 5 | 2009 | 236 | |
| 6 | 2009 | 209 | |
| 7 | 2007 | 197 | |
| 8 | 2009 | 177 | |
| 9 | 2009 | 171 | |
| 10 | 2011 | 160 | |
| 11 | 2020 | 152 | |
| 12 | 1995 | 149 | |
| 13 | 2013 | 135 | |
| 14 | 1996 | 133 | |
| 15 | 2017 | 126 | |
| 16 | 2018 | 119 | |
| 17 | 2012 | 112 | |
| 18 | 2014 | 112 | |
| 19 | 2009 | 100 | |
| 20 | 2014 | 96 |
About Xin Lü
Xin Lü is a scholar working on Epidemiology, Molecular Biology, Oncology, Immunology and Cancer Research, having authored 192 papers that have together received 7.3k indexed citations. Recurring topics across this work include Inflammatory Myopathies and Dermatomyositis (41 papers), Cancer Immunotherapy and Biomarkers (18 papers), Immune cells in cancer (14 papers), Prostate Cancer Treatment and Research (13 papers), Genital Health and Disease (9 papers), Cancer, Hypoxia, and Metabolism (8 papers), Cancer Cells and Metastasis (7 papers) and Epigenetics and DNA Methylation (7 papers). The work is most often cited by research in Cancer Research (1.2k citations), Oncology (2.0k citations), Immunology (1.3k citations), Rheumatology (449 citations) and Molecular Biology (2.1k citations). Xin Lü has collaborated with scholars based in China, United States and Puerto Rico. Frequent co-authors include Yibin Kang, Peter Cram, Yue Li, Stephen L. Kates, Jasvinder A. Singh, Brian R. Wolf, Qinglin Peng, Guochun Wang, Hanbo Yang and Yong Wei. Their work appears in journals such as Cancer Research, Clinical Rheumatology, Scientific Reports, Clinical and Experimental Rheumatology and Cancers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.